Skip to main content
Vaccine information and answers to your COVID-19 questions
Skip to main content
Go to homepage
Akron Children's Hospital > For Families & Patients > Research > Pediatric Clinical Studies > Open Clinical Studies

Efficacy and Safety of SAGE-547 Injection in the Treatment of Super-Refractory Status Epilepticus

Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects With Super-Refractory Status

Description:

For complete study information, please visit clinicaltrials.gov.

Study Status:
Closed
IRB Study ID:
151016
If you are interested in this study or have questions about your child's eligibility, please contact:
Rebecca D. Considine Research Institute, 330-543-3193 or email research@akronchildrens.org
Lead Investigator
James Besunder, DO

Director, Pediatric Critical Care; Pediatric Intensivist
Pediatric Critical Care Medicine (PICU)

Starting Locations:
Career Opportunities
Legal:
Mobile App:

Akron Children's Anywhere:

About Akron Children's

While we are ranked among the best children's hospitals in the country, it's our compassionate approach to treatment that makes us truly exceptional. Through a combination of revolutionary treatments and extraordinary patient experiences, our care does more than heal. It brings the entire family together for emotional support and understanding across multiple locations to reach you in the community where you live. Learn more...

Akron Children's Hospital
One Perkins Square, Akron, Ohio 44308-1062
330-543-1000 • webmaster@akronchildrens.org
An Equal Opportunity Employer
Copyright © 2020, Akron Children's Hospital. All Rights Reserved.
  • Voted Best Doctors 2017-18
  • Magnet Recongnition
  • U.S. News Best Children's Hospitals 2020-2021